{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:39:58Z","timestamp":1787315998335,"version":"build-2736575974"},"reference-count":11,"publisher":"Society of Nuclear Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med. Technol."],"accepted":{"date-parts":[[2025,1,7]]},"published-print":{"date-parts":[[2025,3]]},"DOI":"10.2967\/jnmt.124.268039","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T12:10:25Z","timestamp":1738757425000},"page":"68-71","source":"Crossref","is-referenced-by-count":1,"title":["Logistics of Adopting\n                    <sup>177<\/sup>\n                    Lu-Vipivotide Tetraxetan Therapy in a Community-Based Hospital Setting"],"prefix":"10.2967","volume":"53","author":[{"given":"Kathleen","family":"Marsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Allickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Jesz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Martin-Macintosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"2025032509401126000_53.1.68.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7248"},{"key":"2025032509401126000_53.1.68.2","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1191"},{"key":"2025032509401126000_53.1.68.3","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/ph15101292","article-title":"[177Lu]Lu-PSMA-617 (Lu 177 vipivotide tetraxetan): The first FDA-approved radiotherapeutical for treatment of prostate cancer","volume":"15","author":"Hennrich","year":"2022","journal-title":"Pharmaceuticals (Basel)."},{"key":"2025032509401126000_53.1.68.4","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.10167"},{"key":"2025032509401126000_53.1.68.5","first-page":"S13","article-title":"Overview of prostate-specific membrane antigen","volume":"6","author":"Chang","year":"2004","journal-title":"Rev Urol."},{"key":"2025032509401126000_53.1.68.6","first-page":"P1571","article-title":"PSMA: the Hartford Hospital experience as one of the first adopters in New England [abstract]","volume":"64","author":"Hakim","year":"2023","journal-title":"J Nucl Med."},{"key":"2025032509401126000_53.1.68.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2025032509401126000_53.1.68.8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s40291-022-00594-2","article-title":"Lutetium Lu 177 vipivotide tetraxetan: first approval","volume":"26","author":"Keam","year":"2022","journal-title":"Mol Diagn Ther."},{"key":"2025032509401126000_53.1.68.9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2214\/AJR.22.28237","article-title":"Integrating theranostics into patient care pathways: AJR expert panel narrative review","volume":"220","author":"O\u2019Shea","year":"2023","journal-title":"AJR."},{"key":"2025032509401126000_53.1.68.10","doi-asserted-by":"crossref","first-page":"102524","DOI":"10.1016\/j.ctrv.2023.102524","article-title":"Incorporating radioligand therapy in clinical practice in the United States for patients with prostate cancer","volume":"115","author":"Calais","year":"2023","journal-title":"Cancer Treat Rev."},{"key":"2025032509401126000_53.1.68.11","unstructured":"Pluvicto dosing and administration guide. Novartis website. https:\/\/www.pluvicto-hcp.com\/psma-positive-mcrpc\/dosing-and-administration. Published 2022. Accessed September 15, 2023."}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.124.268039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T12:43:06Z","timestamp":1742906586000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.124.268039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3,5]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.2967\/jnmt.124.268039"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.124.268039","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"value":"0091-4916","type":"print"},{"value":"1535-5675","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]}}}